Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle

Fig. 4

The prognosis of CENPF expression in ACC patients. The OS (a), ROC curves of CENPF at 1-year, 3-year, and 5-year for OS (b), PFS (c), ROC curves of CENPF at 1-year, 3-year, and 5-year for PFS (d), the survival rate of 30-month (e), 60-month (f) and 120-month (g) for patients with CENPFhigh and CENPFlow in ACC at the threshold value of p < 0.05. In time-dependent ROC analysis, the higher the AUC value, the stronger the predictive ability of the gene

Back to article page